/PRNewswire/ Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted.
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.